Results 241 to 250 of about 1,394,686 (289)

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

Advanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun, Haochen Yang, Qing Xu, Xingya Li, Jinxing Lou, Jianchun Duan, Jiachen Xu, Zhuqing Liu, Yong Xia, Zhicai Lin, Linlin Li, Dan Sun, Jiaguo Li, Tao Liu, Jun Guo, Wenfeng Xu, Weimin Zhu, Yi Liu, Boyang Sun, Jia Zhong, Lijie Rong, Qijun Qian, Chenqi Xu, Jie Wang   +23 more
wiley   +1 more source

Artificial intelligence based quantification of T lymphocyte infiltrate predicts prognosis in high grade breast cancer using deep learning and statistical validation. [PDF]

Discov Oncol
Albalawi ES, Qayyum J, Qayyum J.
europepmc   +1 more source

Multimodal deep learning for sports teacher behavior analysis: design and evaluation of a personalized continuing education recommendation system. [PDF]

Sci Rep
Chen Z.
europepmc   +1 more source

Beyond Pathology: A Procedure-Based Approach to Planning and Predicting Outcomes in Robotic Gynaecological Oncology Surgery. [PDF]

BMC Surg
Abdelaziz MAM, Olaleye A, Sabrah K, Mohamed A, Fayad M, Gajjar K.   +5 more
europepmc   +1 more source

Breaking the one-dimensional paradigm: why cardiovascular research needs a multi-systems revolution. [PDF]

Front Physiol
Chaigne S.
europepmc   +1 more source

Digital pathology imaging artificial intelligence in cancer research and clinical trials: An NCI workshop report. [PDF]

J Pathol Inform
Makhlouf HR, Ossandon MR, Farahani K, Lubensky I, Harris LN.   +4 more
europepmc   +1 more source